Monday, December 9, 2019

Anti-diabetes drug Vildagliptin to become 80% cheaper

Anti-diabetes drug Vildagliptin to become 80% cheaper The patents for Vildagliptin in India held by Novartis were expired on December 9, opening the market for cheap rip-offs.

from Moneycontrol Business News https://ift.tt/38q49Ww

No comments:

Post a Comment

HDFC Bank shares slip 1% on Q3 business update. Check details

HDFC Bank faced a stock pullback on January 5, coinciding with the publication of its Q3 FY26 updates. While the news stirred market reactio...